Seeking Alpha

Ligand Pharmaceuticals (LGND -2.3%) trades lower after guiding its FY13 estimates below Street...

Ligand Pharmaceuticals (LGND -2.3%) trades lower after guiding its FY13 estimates below Street consensus at its Analyst Day earlier this morning. The company now expects earn around $0.35 per share on revenue of $41M to $44M, below analysts estimates of $0.43 on $45M. (Webcast replay)

Check out Seeking Alpha’s new Earnings Center »

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs